Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 12/20 | 0.47 |
| ▸ | CTSS | P25774 | 6/20 | 0.45 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16579342 | 0.88 | CTSK (0.42) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL8140881 | 0.86 | CTSK (0.48) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL15289834 | 0.84 | CTSK (0.49) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL23822627 | 0.83 | CTSK (0.48) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL15289784 | 0.83 | CTSK (0.48) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL25527211 | 0.83 | CTSK (0.48) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL805180 | 0.83 | CTSK (0.44) | CTSKCTSSCAPN1CYP1A2CYP2C9 | |
| SCHEMBL15289799 | 0.83 | CTSK (0.49) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL15936967 | 0.83 | CTSK (0.49) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL20170528 | 0.83 | CTSK (0.49) | CTSKCTSSCAPN1CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002422-A1 | REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002422-A1 | REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME | NAAA, NOTUM, ASNS | CTSK 791/4885CTSS 483/4885CAPN1 1472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.